Combining molecular dynamics and docking simulations of the cytidine deaminase from Mycobacterium tuberculosis H37Rv

被引:11
|
作者
Saraiva Macedo Timmers, Luis Fernando [1 ,2 ]
Ducati, Rodrigo Gay [3 ]
Sanchez-Quitian, Zilpa Adriana [1 ,3 ]
Basso, Luiz Augusto [1 ,3 ]
Santos, Diogenes Santiago [1 ,3 ]
de Azevedo, Walter Filgueira, Jr. [1 ,2 ]
机构
[1] Pontificia Univ Catolica Rio Grande do Sul, Programa Pos Grad Biol Celular & Mol, BR-90619900 Porto Alegre, RS, Brazil
[2] Pontificia Univ Catolica Rio Grande do Sul, Lab Bioquim Estrutural LaBioQuest, Fac Biociencias, INCT TB, BR-90619900 Porto Alegre, RS, Brazil
[3] Pontificia Univ Catolica Rio Grande do Sul, INCT TB, CPBMF, BR-90619900 Porto Alegre, RS, Brazil
关键词
Free energy of binding; IC50; determination; Molecular docking simulation; Molecular dynamics simulation; CRYSTAL-STRUCTURE; BIOSYNTHESIS; RESOLUTION;
D O I
10.1007/s00894-011-1045-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytidine Deaminase (CD) is an evolutionarily conserved enzyme that participates in the pyrimidine salvage pathway recycling cytidine and deoxycytidine into uridine and deoxyuridine, respectively. Here, our goal is to apply computational techniques in the pursuit of potential inhibitors of Mycobacterium tuberculosis CD (MtCDA) enzyme activity. Molecular docking simulation was applied to find the possible hit compounds. Molecular dynamics simulations were also carried out to investigate the physically relevant motions involved in the protein-ligand recognition process, aiming at providing estimates for free energy of binding. The proposed approach was capable of identifying a potential inhibitor, which was experimentally confirmed by IC50 evaluation. Our findings open up the possibility to extend this protocol to different databases in order to find new potential inhibitors for promising targets based on a rational drug design process.
引用
收藏
页码:467 / 479
页数:13
相关论文
共 50 条
  • [21] Direct evidence for a glutamate switch necessary for substrate recognition:: Crystal structures of lysine ε-aminotransferase (Rv3290c) from Mycobacterium tuberculosis H37Rv
    Tripathi, Sarvind Mani
    Ramachandran, Ravishankar
    JOURNAL OF MOLECULAR BIOLOGY, 2006, 362 (05) : 877 - 886
  • [22] Expression, purification, crystallization and preliminary X-ray diffraction analysis of the transcriptional repressor SirR from Mycobacterium tuberculosis H37Rv
    Saha, Baisakhee
    Mukherjee, Somnath
    Dutta, Debajyoti
    Das, Amit Kumar
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2009, 65 : 154 - 158
  • [23] In Silico Approach: Anti-Tuberculosis Activity of Caespitate in the H37Rv Strain
    Moreno-Ceballos, Andrea
    Caballero, Norma A.
    Castro, Maria Eugenia
    Perez-Aguilar, Jose Manuel
    Mammino, Liliana
    Melendez, Francisco J.
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (07) : 6489 - 6507
  • [24] Enriching the annotation of Mycobacterium tuberculosis H37Rv proteome using remote homology detection approaches: Insights into structure and function
    Ramakrishnan, Gayatri
    Ochoa-Montano, Bernardo
    Raghavender, Upadhyayula S.
    Mudgal, Richa
    Joshi, Adwait G.
    Chandra, Nagasuma R.
    Sowdhamini, Ramanathan
    Blundell, Tom L.
    Srinivasan, Narayanaswamy
    TUBERCULOSIS, 2015, 95 (01) : 14 - 25
  • [25] In Silico Screening for Novel Inhibitors of DNA Polymerase III Alpha Subunit of Mycobacterium tuberculosis (MtbDnaE2, H37Rv)
    Jadaun, Alka
    Sudhakar, Raja D.
    Subbarao, N.
    Dixit, Aparna
    PLOS ONE, 2015, 10 (03):
  • [26] Mycobacterium tuberculosis H37Rv has a single nucleotide polymorphism in PhoR which affects cell wall hydrophobicity and gene expression
    Schreuder, L. J.
    Carroll, P.
    Muwanguzi-Karugaba, J.
    Kokoczka, Rachel
    Brown, Amanda C.
    Parish, T.
    MICROBIOLOGY-SGM, 2015, 161 : 765 - 773
  • [27] Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations
    Saxena, Shalini
    Abdullah, Maaged
    Sriram, Dharmarajan
    Guruprasad, Lalitha
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2018, 36 (12) : 3184 - 3198
  • [28] Disruption of redox catalytic functions of peroxiredoxin-thioredoxin complex in Mycobacterium tuberculosis H37Rv using small interface binding molecules
    Gurung, Arun Bahadur
    Das, Amit Kumar
    Bhattacharjee, Atanu
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2017, 67 : 69 - 83
  • [29] Recognizing drug targets using evolutionary information: implications for repurposing FDA-approved drugs against Mycobacterium tuberculosis H37Rv
    Ramakrishnan, Gayatri
    Chandra, Nagasuma R.
    Srinivasan, Narayanaswamy
    MOLECULAR BIOSYSTEMS, 2015, 11 (12) : 3316 - 3331
  • [30] In silico Screening of Food and Drug Administration-approved Compounds against Trehalose 2-sulfotransferase (Rv0295c) in Mycobacterium tuberculosis: Insights from Molecular Docking and Dynamics Simulations
    Sharma, Devesh
    Gautam, Sakshi
    Srivastava, Nalini
    Bisht, Deepa
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2024, 13 (01) : 73 - 82